← Blog

AIM - BEYOND THE SCRIBE - Opinion Report

Clinical AI is moving beyond documentation. While AI scribes have demonstrated meaningful benefits in reducing clinician workload and burnout, their value is limited when the clinical workflow remains fragmented after the note is created. This opinion report argues that the next generation of healthcare AI should function as clinical workflow infrastructure connecting the patient encounter to documentation, coding, compliance, and revenue integrity while keeping clinicians in control. AIM’s approach is built around four principles: workflow-first integration, clinician control, privacy by architecture, and connected downstream outcomes. The goal is not simply to generate clinical notes faster, but to reduce friction across the entire clinical workflow. Key takeaway: The future of clinical AI is not more automation for its own sake. It is AI that understands the clinical encounter, follows it downstream, and helps healthcare organizations improve efficiency, compliance, documentation quality, and revenue integrity without taking control away from clinicians.

EXECUTIVE SUMMARY

Investment in clinical AI is accelerating. In the United States, half of healthcare organizations have implemented generative AI, and the conversation has already moved from whether to adopt it to how to integrate it into clinical work1. Yet many of today's solutions automate only the final step of documentation. They make the note faster without addressing what surrounds it. The real problem begins earlier — in the operational and cognitive load that builds from the very start of the clinical encounter, and in the fragmentation between the systems that handle what comes next. AIM's view is straightforward: AI in healthcare should not be a tool that replaces the physician. It should be an infrastructure that sits inside the clinical workflow and operates under the clinician's control.

CLINICAL WORKFLOWS WERE NOT BUILT FOR TODAY

Modern clinical work carries a load its workflows were never designed to hold: the physician's limited time, a growing documentation burden, coding and compliance requirements, revenue leakage, incomplete or scattered clinical data, and a persistent disconnection between the systems that should work together. Each of these is usually treated as a separate problem with a separate tool. But they are symptoms of one underlying condition. The problem is not documentation itself. The problem is the fragmentation that surrounds it.

THE HIDDEN COST OF CLINICAL FRICTION

Clinical work is a chain, and value moves through it in one direction: patient encounter, clinical conversation, documentation, coding, compliance, billing, revenue. A gap at any point becomes a cost at every point after it. An incomplete history produces incomplete documentation; incomplete documentation produces inaccurate or missing codes; a coding gap becomes a claim problem; a claim problem becomes a denial and lost revenue.

This is not theoretical. In the United States, 41% of providers report that at least one in ten claims is denied and 54% say denials are rising — with missing or inaccurate data cited as the most common cause2. The lesson is uncomfortable but clear: revenue is not primarily lost at the billing stage. It is lost upstream, where the record first breaks. Protecting revenue therefore starts with getting the encounter right at the source, not correcting it at the end.

AI SCRIBES ARE A STRONG START AND THE FOUNDATION FOR WHAT COMES NEXT

AI scribes are one of the most valuable advances in clinical documentation, and the evidence is strong. In a US study across six health systems, a clinical AI scribe model reduced clinician burnout from 51.9% to 38.8% within 30 days, with less after-hours documentation, lower cognitive load, and more focused attention on the patient3. For many clinicians, a scribe is the first moment AI visibly gives time back — which is exactly why it is the natural entry point into clinical AI. The opportunity now is to build on that start. A scribe delivers its fullest value when it is connected to the rest of the clinical workflow rather than ending at the note: when the structured record it creates flows into coding, compliance, and billing, and when every output stays under the clinician's review.

This is where AIM begins. AIM Scribe is that entry point, and the structured record it produces continues through the downstream steps that depend on it, keeping the clinician in control at each one. The next generation of clinical AI will not simply document the encounter; it will understand where that encounter goes next.

AI SHOULD FOLLOW THE ENCOUNTER

•WORKFLOW - Workflow-first. AI should operate inside the existing clinical workflow rather than disrupt it. • CONTROL - Clinician-controlled. No clinical or financial output is finalized without the physician's approval. • PRIVACY - Privacy by architecture. Protecting patient data is the starting point of the system's design, not a layer added afterward. • OUTCOMES - One encounter, many outcomes. A single encounter should yield the clinical record, structured data, coding support, compliance checks, and revenue integrity — not just a transcript.

FROM SCRIBE TO CLINICAL WORKFLOW INFRASTRUCTURE

Yesterday EHR to documentation to coding to billing — a linear chain with a manual handoff at every step. Today AI scribe to documentation — the note is faster, but the chain after it is unchanged. Tomorrow Encounter to an AI-enabled workflow that carries the clinical context through documentation, coding, compliance, and revenue. The shift that matters is a category shift: from 'another AI scribe' to clinical workflow infrastructure.

WHAT AI SHOULD AND SHOULD NOT DO

Trust in clinical AI is defined by a clear division of roles: AI generates, AI suggests, AI checks — the clinician approves. No output becomes part of the record until a physician confirms it. That trust must be built into the data architecture, not bolted on: personal identifiers removed at the source before any AI step; patient data kept within the healthcare institution's own environment; no unnecessary identifiers collected or stored; no retention of patient audio; and clinician approval as the final gate.

WHAT HEALTHCARE ORGANIZATIONS SHOULD ASK BEFORE BUYING AI

  1. Does it fit our existing clinical workflow?
  2. Where does patient data go?
  3. Who controls the AI-generated output?
  4. Does it improve only documentation, or the entire downstream process?
  5. Can it support coding and compliance?
  6. Does it reduce operational friction — or simply move it somewhere else?
  7. Can its impact be measured?

The future is not more AI. It is better workflows. Healthcare does not need AI for the sake of AI. It needs systems that understand how clinical work actually happens. AIM's view is simple: the value of AI in healthcare should be measured not by how much text it can generate, but by how much friction it can remove across the clinical workflow while keeping clinicians in control.

SOURCES & METHOD This report draws on three public, primary (or clearly primary-attributed) studies. The quantitative findings are from the US market; implications for Turkey are structural and do not include a Turkey-specific measurement. 1 McKinsey & Company — "Generative AI in healthcare: Current trends and future outlook" (April 2026). US healthcare organizations survey (Q4 2025); reported by Becker's Hospital Review, 17 April 2026. 2 Experian Health — "2025 State of Claims Report." US; 250 revenue-cycle decision-makers; June–July 2025. 3 Olson KD, Meeker D, Troup M, et al. — "Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout." JAMA Network Open. 2025;8(10):e2534976. US; 263 clinicians; 6 health systems.